Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel (Q46917099)
Jump to navigation
Jump to search
scientific article published on 9 December 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel |
scientific article published on 9 December 2014 |
Statements
1 reference
Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel (English)
1 reference
Mary-Ellen Taplin
1 reference
Tomasz M Beer
1 reference
Celestia Higano
1 reference
Eric J Small
1 reference
Rahul R Aggarwal
1 reference
Vivian K Weinberg
1 reference
Charles J Ryan
1 reference
Amy M Lin
1 reference
Joshi Alumkal
1 reference
Julie N Graff
1 reference
Luke T Nordquist
1 reference
Isheen Herrera
1 reference
9 December 2014
1 reference
13
1 reference
3
1 reference
e191-8
1 reference